Skip to content
triangle-white-good

FEATURED ARTICLE

From Managed Healthcare Executive: "We Need a Better Clinical Trial Recruitment Process"

FEATURED ARTICLE

From Managed Healthcare Executive: "We Need a Better Clinical Trial Recruitment Process"

VIEW BY
second-menu-section

NEWS PAGE

15 July, 2019

ASCO 2019: CEO Carla Balch Discusses How to Achieve Clinical Trial Success

At ASCO 2019, CEO Carla Balch sat down with Oncology Central. She discussed how Inteliquet brings "one source of truth" to the stakeholders of clinical trial process, including Pharma, CROs, patients, and providers.
READ MORE

07 June, 2019

From Biocentury.com: ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

Staff Writer Allison Johnson speaks to CEO Carla Balch about how drug developers can match more patients to clinical trials by broadening eligibility criteria and encouraging trial enrollment in community settings.
READ MORE

20 May, 2019

From genomeweb.com: Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract

READ MORE

20 May, 2019

Press Release: Inteliquet Signs Cooperative R&D Agreement (CRADA) with the National Cancer Institute

Inteliquet announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI). The principal goal of this research agreement is to develop a clinic-ready, web-based tool, using NCI’s Oncogenomics browser with Inteliquet’s proprietary Precision Medicine Platform to aid clinicians in therapeutic decision-making.
READ MORE

16 May, 2019

From Forbes.com: Genomic Data Carve A New Path For Consumers, Clinical Trials

CEO Carla Balch discusses how Inteliquet is reimagining the clinical trial process using health and genetic data.
READ MORE

INTELIQUET MEDIA CONTACT

Chris Gale, Vice President

Greentarget Global Group

Phone: 646-695-2883

Email: cgale@greentarget.com

LEARN MORE

Would you like a demo? More information? Let us know how we can help. We’ll contact you shortly.